Data from EMC - Curated by EPG Health - Last updated 19 August 2016


Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Nebcin is indicated for the treatment of the following infections caused by susceptible micro-organisms:

Central nervous system infections, including meningitis, septicaemia and neonatal sepsis

Gastro-intestinal infections, including peritonitis, and other significant infections such as complicated and recurrent urinary tract infections, including pyelonephritis and cystitis

Lower respiratory tract infections, including pneumonia, bronchopneumonia and acute bronchitis

Skin, bone and soft tissue infections, including burns

Nebcin may be considered in serious staphylococcal infections for which penicillin or other less potentially toxic drugs are contra-indicated and when bacterial susceptibility testing and clinical judgement indicate its use.


Full Prescribing information

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Fluid Management

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

+ 2 more

Hereditary ATTR amyloidosis

Hereditary ATTR amyloidosis

Explore the pathophysiology, epidemiology and multi-system symptoms associated with hereditary ATTR amyloidosis, as well as how to achieve an early and accurate diagnosis.

Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrotic interstitial lung disease that occurs mostly in older adults, is limited to the lungs and often displays a characteristic imaging and histological appearance. Find out how to diagnose IPF and the latest interventions available for patients living with this burden.

Load more

Related Content

More information

Category Value
Orphan designation No
Type POM
Marketing authorisation holder Flynn Pharma Ltd